Mead Johnson (MJN) Misses Q4 EPS by 10c; Issues Light FY15 EPS Outlook

Mead Johnson (NYSE: MJN) reported Q4 EPS of $0.78, $0.10 worse than the analyst estimate of $0.88. Revenue for the quarter came in at $1.09 billion versus the consensus estimate of $1.11 billion.

Mead Johnson sees FY2015 EPS of $3.90-$4.00, versus the consensus of $4.12.

For earnings history and earnings-related data on Mead Johnson (MJN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c